Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Australian vets treat anteater for ant allergy
Ants are an echidna’s main source of food.
Echidna in recovery after receiving allergen-specific vaccine

Vets and keepers at a zoo in Australia are celebrating after successfully treating an echidna who was found to be allergic to ants.

Ants are an echidna’s main source of food, so staff at Healesville Sanctuary, Victoria, were surprised when one of their spiny residents had an unusual reaction to them.

The echidna, named Matilda, was first presented to the sanctuary in 2010 after she was accidentally dug up from her burrow. Thought to be around three months old, she would have just started eating termites and ants.

Keepers became surrogates to Matilda as she had not been weaned, and she soon settled into her new environment. But at two years old, the skin around her eyes started to look a little inflamed.

The keepers provided topical treatments and cleaned the eyes but, after a noticeable spread of the inflammation, Matilda was transferred to the Melbourne Veterinary Specialist Centre for allergy testing.

To determine the cause of the inflammation, specialists injected a range of know antigens under Matilda’s skin and observed her for reactions. Once ants were identified as the cause, specialists got to work on developing an allergen-specific vaccine that was unique to her. She then underwent a period of ‘desensitisation’.

‘Matilda’s treatment plan required her vaccine to be given in small, regular doses, exposing her to enough of the allergen to cause an immune response but not so much that it would cause an adverse reaction,’ a spokesperson for Healesville Sanctuary explains. ‘In short, Matilda’s immune system was being trained to learn how to manage and respond to the identified allergens.

‘While time-consuming, this process of desensitisation has been highly effective and become a lifelong solution for Matilda’s allergies.’

Matilda responded well to the treatment and has now been vaccine-free for six months. Thought to be the world’s first allergic echidna, keepers are optimistic that she will now go on to live a long and allergy-free life.

Become a member or log in to add this story to your CPD history

Cold-water dip to raise funds for Vetlife

News Story 1
 The veterinary mental health charity Vetlife is inviting the veterinary community to join it for a sponsored cold-water dip.

The event will take place at Walpole Bay, Margate, on 17 May during Mental Health Awareness Week. Participants of all abilities can join in the challenge and are advised to bring a towel, a hot drink, a snack, and warm clothes to get changed into afterwards.

Those taking part are being asked to try to raise 100 each to support the work of the charity.

Details about how to take part can be found here

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.